IN8BIO, INC. — Director's Dealing 2021

Dec 10, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2021-12-01

Reporting Person: Rochlin Kate (Chief Operating Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$6.74	2030-10-04	Common Stock (46984)		Direct
Employee Stock Option (right to buy)	$5.36	2031-01-31	Common Stock (41616)		Direct
Employee Stock Option (right to buy)	$10.00	2031-07-28	Common Stock (35000)		Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to the option vested on October 1, 2021 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

F2: Twenty-five percent (25%) of the shares subject to the option shall vest on February 1, 2022 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

F3: One forty-eighth (1/48th) of the shares subject to the option shall vest monthly commencing on August 29, 2021, subject to the Reporting Person continuing to provide service through each such date.